SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors react to a large $15 billion stock offering intended to fuel capital expenditures and expansion within the semiconductor and AI sectors. While some in the community express frustration over potential dilution and share price volatility, others view the move as a strategic step to secure long-term growth and compete against industry rivals.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is capturing significant market attention following a strategic collaboration and investment from Boeing, which involves the acquisition of Wisk Aero and other key subsidiaries to bolster its physical AI and defense capabilities. While bullish investors view the deal as a major de-risking event that validates the company's long-term potential, community sentiment remains split as some skeptics point to potential share dilution and continued skepticism surrounding the firm's flight certification progress.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is under scrutiny as investors closely monitor the upcoming Phase 3 IZAR-1 trial results, with community discussion highlighting a mix of cautious optimism regarding potential 'best-in-class' efficacy and frustration over the company's opaque communication timeline. While some stakeholders express confidence in the drug's long-term competitive profile and potential for acquisition, many are actively debating how the reported trial data will influence the stock's valuation relative to the broader immunology landscape.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is currently trending as investors debate reports that the company may withdraw its multibillion-dollar takeover bid for eBay. The community remains deeply polarized, with bulls viewing the potential pivot as a strategic move to preserve capital, while critics express frustration over ongoing share dilution and a lack of clear direction from leadership.

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.

Tenax Therapeutics Inc

Tenax Therapeutics is experiencing extreme downward pressure, with shares plummeting following the announcement that the company's Phase 3 LEVEL trial failed to reach its primary endpoint. The community is actively debating whether the significant sell-off is an overreaction given the company's remaining cash position or a justified response to the biotech firm's clinical failure.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following strong Phase 2 data for its non-hormonal menopause drug, ABCL635, which exceeded internal targets and triggered community discussion about a potential clinical re-rating. While the stock has seen significant volatility as investors weigh the breakthrough trial results against its recent sharp run-up, the community remains intensely focused on the long-term validation of its antibody discovery platform.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors gear up for the next earnings release, with significant community debate focused on the company's shift toward AI infrastructure through the Quake AI platform and Northern Data acquisition. Shareholders are closely watching for signs of institutional momentum and potential short-squeeze activity, while discussing the impact of strategic partnerships on the firm's long-term valuation.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as GameStop continues to aggressively increase its ownership stake and press for a potential hostile takeover, sparking intense debate among investors about the feasibility and long-term implications of the deal. The community remains divided, with supporters highlighting the potential for disruptive e-commerce synergies while detractors express skepticism regarding GameStop's financing strategy and the eBay board's ongoing resistance.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is experiencing intense volatility driven by strong quarterly earnings results, contrasting with broader software sector concerns regarding AI-driven disruption. The community is sharply divided, with some investors accumulating shares due to the company's profitability and cash position, while others remain bearish due to fears of AI competition and sustained selling pressure.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is currently trending as the market awaits a long-overdue decision on its drug candidate, with community sentiment deeply polarized between bullish institutional holders anticipating approval and bearish retail investors betting on a significant downside gap fill due to potential dilution and funding concerns. The conversation is heavily focused on the uncertainty surrounding the timing of the FDA's regulatory decision and the high-stakes commercialization path ahead.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRMD $FMS  
 
Guys 
 
be careful who you are following and influence your investment decisions. 
Noname is one of the most dumb cherry picker I ever found in any online board. It is even a BAD ai user. 
I never thought it was possible to use bad AI, but I had to review my thoughts. 
Someone recently post here the internal memo of FMC leaving the boat for Defencath. Instead of being grateful to receive this insight, some of you are PERMABULLING their line of thought trying to find anywhere any potential confirmation that the info posted was fake. 
Going back to the root sense of my message. 
 
Where the hell the screenshot posted is related to Defencath? 
 
It&#39;s boned into this cherrypicker&#39;s attitude to manipulate adn exploit content like this. 
Be careful guys. 
 
You are following a bad person with very wrong attitude.

Clark K

Genco Oliveoil

Jack Dove

$CRMD $FMS 

“innovation means not only introducing new therapies, but also rigorously measuring their impact.” FMC CMO

StockTwits for iOS

CorMedix Inc

Fresenius Medical Care AG & Co. KGAA

Noname2022

StockTwits Web

  
 
Guys 
 
be careful who you are following and influence your investment decisions. 
Noname is one of the most dumb cherry picker I ever found in any online board. It is even a BAD ai user. 
I never thought it was possible to use bad AI, but I had to review my thoughts. 
Someone recently post here the internal memo of FMC leaving the boat for Defencath. Instead of being grateful to receive this insight, some of you are PERMABULLING their line of thought trying to find anywhere any potential confirmation that the info posted was fake. 
Going back to the root sense of my message. 
 
Where the hell the screenshot posted is related to Defencath? 
 
It's boned into this cherrypicker's attitude to manipulate adn exploit content like this. 
Be careful guys. 
 
You are following a bad person with very wrong attitude.

Andrea from Italy

@Yamauchii 

Most seemed to think it wasn’t genuine…

How is one to prove or disprove? 

Earnings calls will be here soon enough!

Andy

Mark

Fred Garcia

 

Most seemed to think it wasn’t genuine…

How is one to prove or disprove? 

Earnings calls will be here soon enough!

@Yamauchii  Mind your business that I mind mine.

@Maissessap I mind my business, don&#39;t worry. :)

hsainu

@Yamauchii @Maissessap Are you saying the guy that posted the &quot;memo&quot;...you know, the guy that put his friends job on the line was all meant to help us out and we should all be grateful?!??

StockTwits For Android 

 Are you saying the guy that posted the "memo"...you know, the guy that put his friends job on the line was all meant to help us out and we should all be grateful?!??

@Andy1063 @Maissessap do you prefer to see a - 90% drop in H2 revenue as a surprise?

 do you prefer to see a - 90% drop in H2 revenue as a surprise?

@Yamauchii @Maissessap Of course not. But please don&#39;t pretend that what he did was ONLY to save Cormedix investors from themselves as if he didn&#39;t have an alterior motive such as having such disdain for another poster in our room that he was willing to risk his friends job. And of course all of this is under the premise that the &quot;memo&quot; is real. I can&#39;t speak for yourself but for me, I don&#39;t assume. It&#39;s either real or it&#39;s fake. You don&#39;t know the real truth anymore then I do. That&#39;s why I&#39;ll wait for the next quarterly to hear what the CEO says to reserve judgment. I haven&#39;t seen one poster in the room say they sold because of that &quot;memo&quot;. So, in the end, what did that guy really accomplish? I&#39;m not sure if you noticed or not but he&#39;s no longer on Stocktwits. Was the reason he was booted for sharing inside information or was it because stock manipulation. Who knows.

John Dollinger

 Of course not. But please don't pretend that what he did was ONLY to save Cormedix investors from themselves as if he didn't have an alterior motive such as having such disdain for another poster in our room that he was willing to risk his friends job. And of course all of this is under the premise that the "memo" is real. I can't speak for yourself but for me, I don't assume. It's either real or it's fake. You don't know the real truth anymore then I do. That's why I'll wait for the next quarterly to hear what the CEO says to reserve judgment. I haven't seen one poster in the room say they sold because of that "memo". So, in the end, what did that guy really accomplish? I'm not sure if you noticed or not but he's no longer on Stocktwits. Was the reason he was booted for sharing inside information or was it because stock manipulation. Who knows.